WO2015049966A1 - Procédé de détection de déplacement d'électrode de neurostimulation, électrode de neurostimulation et système de neurostimulation - Google Patents

Procédé de détection de déplacement d'électrode de neurostimulation, électrode de neurostimulation et système de neurostimulation Download PDF

Info

Publication number
WO2015049966A1
WO2015049966A1 PCT/JP2014/074049 JP2014074049W WO2015049966A1 WO 2015049966 A1 WO2015049966 A1 WO 2015049966A1 JP 2014074049 W JP2014074049 W JP 2014074049W WO 2015049966 A1 WO2015049966 A1 WO 2015049966A1
Authority
WO
WIPO (PCT)
Prior art keywords
nerve stimulation
unit
stimulation electrode
stimulation
electrocardiogram waveform
Prior art date
Application number
PCT/JP2014/074049
Other languages
English (en)
Japanese (ja)
Inventor
萌 後藤
Original Assignee
オリンパス株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オリンパス株式会社 filed Critical オリンパス株式会社
Publication of WO2015049966A1 publication Critical patent/WO2015049966A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36053—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36142—Control systems for improving safety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056—Transvascular endocardial electrode systems

Definitions

  • the present invention relates to a method for detecting movement of a nerve stimulation electrode, more specifically, a method for detecting movement of a nerve stimulation electrode that preferably detects movement after placement of the nerve stimulation electrode, and a nerve stimulation electrode to which the method can be preferably applied, and It relates to a nerve stimulation system.
  • Patent Document 1 describes a medical device used for such treatment.
  • the medical device described in Patent Document 1 includes a cylindrical main body or an arched spring that can be expanded in a blood vessel, and the cylindrical main body or the arched spring is expanded in the blood vessel to be placed in the blood vessel.
  • the nerve stimulation electrode placed in the blood vessel stimulates the nerve through the blood vessel wall
  • the nerve stimulation electrode is placed in a position where nerve stimulation can be performed as preferably as possible in the blood vessel in consideration of the position of the nerve parallel to the blood vessel.
  • the nerve stimulation electrode may move after placement due to the patient's body movement or the conscious or unconscious removal operation by the patient.
  • a suitable electrical stimulation cannot be performed due to a change in the positional relationship between the nerve stimulation electrode and the nerve, and appropriate measures such as correction of the indwelling position should be taken immediately.
  • the medical device described in Patent Document 1 has a problem that even if the nerve stimulation electrode moves after placement, the movement cannot be detected.
  • the present invention has been made in view of the above-described problems, and an object thereof is to provide a movement detection method for a nerve stimulation electrode that can suitably detect movement of the nerve stimulation electrode in a blood vessel. . Another object of the present invention is to provide a nerve stimulation electrode and a nerve stimulation system capable of suitably detecting movement using the movement detection method.
  • an electrocardiogram waveform is acquired by the nerve stimulation electrode, and the nerve stimulation electrode is based on the electrocardiogram waveform. It is determined whether or not it has moved.
  • the electrocardiogram waveform is compared with a reference waveform prepared in advance, and the nerve stimulation electrode is placed in the heart. You may determine whether it moved to the approaching direction.
  • the nerve stimulation electrode movement detection method when the maximum value of the P wave or the R wave in the electrocardiographic waveform is equal to or greater than a predetermined threshold value. It may be determined that the nerve stimulation electrode has moved in a direction approaching the heart.
  • the magnitude relationship between the maximum values of the P wave and the R wave in the electrocardiogram waveform is the P wave in the reference waveform.
  • the magnitude relationship of the maximum value of the R wave is reversed, it may be determined that the nerve stimulation electrode has moved in a direction approaching the heart.
  • the nerve stimulation electrode when the baseline of the electrocardiographic waveform changes to a non-linear shape, the nerve stimulation electrode is a heart. It may be determined that it has moved in a direction approaching.
  • the nerve stimulation electrode when the P wave in the electrocardiographic waveform has a shape having a plurality of peaks, the nerve stimulation electrode is You may determine with having moved to the direction which approaches the heart.
  • the nerve stimulation electrode placed in the blood vessel has an urging member that can be elastically deformed, and is provided in the indwelling portion locked in the blood vessel.
  • the stimulation unit has three or more electrodes arranged apart from each other in the longitudinal direction of the nerve stimulation electrode. May be.
  • the electrocardiographic waveform acquisition unit has at least two electrodes, and the two electrodes are the nerves. You may arrange
  • a nerve stimulation system includes a nerve stimulation electrode according to any one of the seventh aspect to the ninth aspect and an electrocardiogram acquired by the electrocardiographic waveform acquisition unit. And an analysis unit that determines whether or not the stimulation unit has moved based on a shape.
  • the nerve stimulation system is acquired by the nerve stimulation electrode according to the eighth aspect, the stimulation generation unit that generates the stimulation signal, and the electrocardiographic waveform acquisition unit.
  • An analysis unit that determines whether or not the stimulation unit has moved based on an electrocardiogram waveform, and a control unit that controls the stimulation generation unit based on the determination of the analysis unit.
  • the control unit changes a combination of electrodes to which the stimulation signal is applied among the electrodes of the stimulation unit.
  • movement of the nerve stimulation electrode in the blood vessel can be suitably detected.
  • the movement of a nerve stimulation electrode can be detected suitably using the movement detection method of this invention.
  • FIG. 1 is a schematic diagram showing a nerve stimulation system 1 including the nerve stimulation electrode of the present embodiment.
  • the nerve stimulation system 1 is a system that treats tachycardia, chronic heart failure, and the like by stimulating the vagus nerve.
  • the nerve stimulation system 1 includes a stimulation generator 10 and a stimulation lead (neural stimulation electrode) 20.
  • the stimulation generator 10 generates a nerve stimulation signal based on a predetermined parameter.
  • a stimulation lead (neural stimulation electrode) 20 is connected to the stimulation generator 10 and placed in the blood vessel.
  • the stimulus generator 10 includes a stimulus generator 11, an analyzer 12, and a controller 13.
  • the stimulus generator 11 generates a stimulus signal.
  • the analysis unit 12 analyzes the electrocardiogram waveform acquired by the stimulation lead 20.
  • the controller 13 is connected to the stimulus generator 11 and the analyzer 12 and controls the stimulus generator 10 as a whole.
  • the stimulus signal generated by the stimulus generator 11 is sent to the stimulus lead 20.
  • the analysis unit 12 analyzes the electrocardiogram waveform sent from the stimulation lead 20 and repeatedly determines whether the stimulation lead 20 has moved after placement. The flow of determination in the analysis unit 12 will be described later.
  • FIG. 2 is a schematic diagram showing the stimulation lead 20 placed in the superior vena cava Sv, which is a blood vessel connected to the heart Ht.
  • the stimulation lead 20 includes an indwelling unit 21, a conducting wire unit 26, a stimulation unit 31, and an electrocardiographic waveform acquisition unit 36.
  • the indwelling part 21 is locked in the blood vessel.
  • the conducting wire part 26 connects the indwelling part 21 and the stimulus generator 10.
  • the stimulation part 31 has a pair of electrodes 32 and 33 to which a stimulation signal is applied.
  • the electrocardiogram waveform acquisition unit 36 includes a pair of electrodes 37 and 38 different from the stimulation unit 31.
  • the indwelling part 21 includes an urging member 22 that can be elastically deformed.
  • the biasing member 22 When the stimulation lead 20 is introduced into the blood vessel, the biasing member 22 is deformed and can be accommodated inside an introducer or the like.
  • the biasing member 22 has a shape that can be expanded into a shape before deformation and locked in the blood vessel when no external force is applied.
  • the material of the urging member 22 can be selected from various shape memory alloys in consideration of biocompatibility.
  • the surface of the urging member 22 may be coated or surface-treated for the purpose of enhancing biocompatibility or suppressing thrombus formation.
  • the conducting wire portion 26 is formed by covering a conducting wire made of a conductor with an insulating material, and can be selected from various known materials in consideration of biocompatibility and the like.
  • the pair of electrodes 32 and 33 of the stimulation unit 31 are attached to the indwelling unit 21 with their conductive surfaces exposed, and a stimulation signal is applied between the pair of electrodes 32 and 33.
  • the pair of electrodes 32 and 33 may be provided on the same urging member, or may be provided on different urging members.
  • the electrodes 32 and 33 of the stimulation part 31 are connected to the conductor part 26 by wiring (not shown) provided along the biasing member 22.
  • the basic structure of the pair of electrodes 37 and 38 of the electrocardiogram waveform acquisition unit 36 and the connection mode of the lead wire unit 26 are generally the same as those of the electrodes 32 and 33 of the stimulation unit 31, and all four electrodes are connected to other electrodes. Insulation is ensured.
  • one electrode 37 is provided on the biasing member 22 located at the distal end portion of the indwelling portion 21.
  • the other electrode 38 is provided on the outer peripheral surface of the conducting wire portion 26 and is located on the proximal side with respect to the indwelling portion 21.
  • the pair of electrodes 37 and 38 of the electrocardiogram waveform acquisition unit 36 have a positional relationship such that the pair of electrodes 32 and 33 of the stimulation unit 31 are sandwiched from both sides in the longitudinal direction of the stimulation lead 20.
  • the electrode 38 is not necessarily present on the conducting wire portion 26 and may be provided on the urging member 22. Even if comprised in this way, the structure which pinches
  • the range from the connection part of the indwelling part 21 and the conductor part 26 to the part where the electrode 38 is provided is not easily bent by a core rod or the like so that a substantially straight state is maintained. It is configured.
  • the electrocardiographic waveform acquisition unit 36 does not substantially move relative to the indwelling unit 21 and the stimulation unit 31 provided in the indwelling unit 21 except for a slight displacement accompanying the deformation of the biasing member 22. It is configured.
  • the stimulation lead 20 is first introduced into the patient's blood vessel using an introducer or the like. Next, the stimulation lead 20 is placed in the blood vessel by expanding the placement portion 21 at the target position and locking it in the blood vessel. After the stimulation lead 20 is placed, the stimulation generator 10 is operated at a predetermined timing, and a stimulation signal is applied from the stimulation unit 31 to the nerve Vn through the blood vessel wall to perform nerve stimulation treatment for the patient.
  • the electrocardiographic waveform of the patient is acquired by the electrocardiographic waveform acquisition unit 36 continuously or intermittently.
  • the acquired electrocardiogram waveform is transmitted to the analysis unit 12 of the stimulus generator 10.
  • the analysis unit 12 analyzes the electrocardiogram waveform for the presence / absence and type of abnormality related to the size of the electrocardiogram waveform, so that the stimulation lead 20, particularly the indwelling unit 21 and the stimulation unit 31 provided in the indwelling unit 21 after placement. It is determined whether or not has moved.
  • An example of the first determination criterion is a value of a specific parameter in the electrocardiogram waveform such as the magnitude (particularly the maximum value) of the P wave and / or the R wave.
  • the upper side of FIG. 3 is an example of a general electrocardiogram waveform acquired with electrodes placed on the body surface, and the lower side is acquired by the electrocardiogram waveform acquisition unit 36 of the stimulation lead 20 placed in the blood vessel. It is an example of an electrocardiogram waveform. The same applies to FIGS.
  • the electrocardiographic waveform increases as shown in the lower part of FIG. 4 when the acquired electrode approaches the heart, and decreases as shown in the lower part of FIG. 5 when moving away from the heart.
  • the value of an arbitrary parameter of the electrocardiogram waveform is compared with a parameter of a standard electrocardiogram waveform (hereinafter sometimes referred to as a “reference waveform”), and the difference between the two is equal to or greater than a predetermined value or ratio. It is possible to determine whether or not the stimulating unit 31 has moved by analyzing whether or not there is the analysis unit 12.
  • the parameter for example, the maximum value of a certain wave such as the maximum value of the R wave or the maximum value of the P wave, or the amplitude represented by the difference between the maximum value and the minimum value of the P wave or QRS wave is used. However, it is not limited to this.
  • FIG. 6 is a flowchart illustrating an example of a determination flow in the analysis unit 12 in a case where determination is performed using the maximum value of the R wave, and illustrates one mode of the nerve stimulation electrode movement detection method of the present invention.
  • the analysis part 12 acquires the maximum value of the R wave in the acquired electrocardiogram waveform.
  • the analysis unit 12 determines whether or not the maximum value of the acquired R wave exceeds 1.2 times (a predetermined threshold) the maximum value of the R wave in the reference waveform.
  • the determination in step S20 is Yes, the process proceeds to step S21, and the analysis unit 12 determines that the stimulation unit 31 has moved in a direction approaching the heart and ends the process. If the determination in step S20 is No, the process proceeds to step S30.
  • step S30 the analysis unit 12 determines whether or not the acquired maximum value of the R wave is less than 0.8 times the maximum value of the R wave in the reference waveform similar to the standard electrocardiogram waveform. judge.
  • the process proceeds to step S31, and the analysis unit 12 determines that the stimulation unit 31 has moved in the direction away from the heart and ends the process.
  • determination in step S30 is No, a process progresses to step S32, an analysis part determines with the stimulation part 31 not moving, and complete
  • step S20 for determining whether or not the stimulating unit 31 has moved in a direction approaching the heart and step S30 for determining whether or not the stimulating unit 31 has moved in a direction away from the heart, May be reversed.
  • the threshold values in steps S20 and S30 may be changed as appropriate.
  • the parameter used for the determination may be replaced with another parameter, or the determination may be performed by combining a plurality of parameters.
  • an electrocardiographic waveform acquired by the electrocardiographic waveform acquisition unit immediately after placement may be stored in a storage unit (not shown) of the stimulation generator 10 and used.
  • an average electrocardiogram waveform at a standard indwelling position in neurostimulation treatment or a parameter value in the electrocardiogram waveform may be stored in advance in the stimulation generator 10 as a reference waveform.
  • the maximum value of the P wave is larger than the maximum value of the R wave, and the magnitude relationship of the maximum value is reversed from that of the electrocardiogram waveform shown on the upper side. This is a result that the atrial action potential acquired by the electrocardiogram waveform acquisition unit 36 is acquired larger than the action potential of the ventricle because the stimulation unit 31 has approached the atrium considerably.
  • the maximum value of the R wave is larger than the maximum value of the P wave, but if the shape of the electrocardiographic waveform is changed so that the maximum value of the P wave becomes larger than the maximum value of the R wave after that, It can be determined that the stimulation unit 31 has moved in a direction approaching the heart.
  • the reversal of the magnitude relationship may be compared with a reference waveform, or the magnitude relation may be monitored at all times to capture the event of reversal.
  • the base line of the electrocardiogram waveform is not linear like the standard electrocardiogram waveform, and the maximum value of the electrocardiogram waveform fluctuates periodically. All waveforms including the R wave and the R wave fluctuate up and down. This indicates that as a result of the indwelling portion 21 entering the atrium, the locking by the biasing member does not work, and the stimulation portion 31 is moved by the blood flow in the atrium. Therefore, it can be determined that the stimulation unit 31 has moved in a direction approaching the heart due to the base line changing to a non-linear shape.
  • the stimulating unit 31 it is also possible to determine whether or not the stimulating unit 31 has moved based on the presence or absence of a part or all of the ECG waveform. This is because, as the stimulation unit 31 approaches the heart, the heart potential vector with respect to the electrocardiogram waveform acquisition unit 36 changes, and therefore the presence or absence of movement of the stimulation unit 31 in the direction of approaching the heart mainly. It is suitable for the determination.
  • the acquired electrocardiogram waveform and the reference waveform can be compared as a whole.
  • the electrocardiogram waveform for 3 beats acquired by the electrocardiogram waveform acquisition unit 36 is processed as point sequence data, and the correlation coefficient with the reference waveform for 3 beats is calculated. Then, it is possible to determine whether or not the stimulation unit 31 has moved by setting a predetermined threshold value for the correlation coefficient.
  • the determination based on the correlation coefficient is merely an example of an overall comparison, and other known various methods can also be used. It is also possible to combine a plurality of types of determination criteria described above.
  • the nerve stimulation electrode movement detection method it is determined whether or not the nerve stimulation electrode has moved based on the electrocardiogram waveform acquired by the nerve stimulation electrode. . Therefore, it is possible to easily detect the movement of the nerve stimulation electrode without requiring a special parameter for movement detection and without requiring a special configuration for the parameter.
  • the electrocardiographic waveform acquisition unit 36 is provided separately from the stimulation unit 31 that performs nerve stimulation.
  • the electrocardiographic waveform acquisition unit 36 is substantially held in a relative position with respect to the stimulation unit 31 provided in the indwelling unit 21. Therefore, by performing the above-described movement detection method based on the electrocardiogram waveform acquired by the electrocardiogram waveform acquisition unit 36, it is possible to suitably detect the movement of the indwelling unit 21 and the stimulation unit 31 after the indwelling.
  • an electrocardiogram waveform can be acquired independently of nerve stimulation.
  • a part of the stimulation unit can be used as an electrocardiogram waveform acquisition unit, and the configuration can be simplified. It is preferable because of its advantages.
  • an electrocardiogram waveform is acquired simultaneously with the nerve stimulation, an electrocardiogram waveform to which the noise of the nerve stimulation is added is acquired and affects the determination accuracy.
  • a specific method of shifting the timing between the neural stimulation and the acquisition of the electrocardiographic waveform can be set as appropriate.
  • an electrocardiogram waveform may be acquired at the time of pause, or when stimulation is being performed.
  • an electrocardiographic waveform may be acquired between pulses of the stimulation signal. Any of these methods can reduce noise caused by the stimulus signal.
  • the control unit 13 when the movement of the stimulation lead 20 is detected, the control unit 13 can perform various processes. Suitable treatment can be performed by the treatment.
  • the first example of processing by the control unit 13 is notification to a patient, a medical staff, or the like. For example, sound, light, vibration or the like is generated in the stimulus generation device 10, a signal is transmitted to a biological monitor or a remote monitoring device connected to the patient, a predetermined display is performed, or a nurse call is performed, Calling a preset contact or sending an email. As a result, a person who has recognized the notification can take appropriate measures such as correcting the position of the stimulation unit.
  • a second example of the processing of the control unit 13 is modification of the stimulus signal generated by the stimulus generation unit 11.
  • stop of stimulation pulse unit or one set unit of stimulation and pause
  • increase / decrease of stimulation energy and the like.
  • the stimulation energy can be increased or decreased by adjusting the current value, voltage value, pulse width, frequency, duration, etc. of the stimulation signal.
  • an example in which the action on the heart is suppressed by synchronizing the timing of applying the stimulation signal with the refractory period of the heart when the stimulating unit 31 approaches the heart is also this example. include.
  • the third example of the processing of the control unit 13 is recording of detection contents.
  • the detection content can be stored in a storage unit or the like every time a predetermined interval or movement is detected, and output after removal of the nerve stimulation system, thereby making it possible to grasp the movement of the indwelling stimulation unit. At this time, you may memorize
  • FIG. 10 is a schematic diagram showing the stimulation lead 50 in the present embodiment.
  • the stimulation unit 51 includes three electrodes 52, 53, and 54. Each of the electrodes 52, 53, 54 is attached to the biasing member 22 with an interval in the longitudinal direction of the stimulation lead 50.
  • the nerve stimulation system of this embodiment provided with the stimulation lead 50 has the same effect as the nerve stimulation system 1 described above.
  • nerve stimulation is performed using the electrodes 52 and 53, which are the two electrodes on the distal end side, among the electrodes of the stimulation unit 51 in the initial setting.
  • the control unit 13 selects two electrodes 53 on the proximal end side as shown in FIG. Switch to 54. By this switching, a part of the movement of the indwelling part 21 is absorbed, and the position of the two electrodes to which the stimulation signal is applied in the blood vessel is preferably suppressed from greatly changing from the state before the movement.
  • the stimulation unit 51 since the stimulation unit 51 includes the three electrodes 52, 53, and 54, the combination of the two electrodes to which the stimulation signal is applied among the three electrodes is appropriately changed. Thus, even when the stimulation unit moves, a suitable nerve stimulation treatment can be performed.
  • the control unit 13 applies the stimulation signal when the analysis unit 12 detects that the stimulation unit 51 has moved in the direction approaching the heart. Since the electrodes to be switched are moved within a certain range, the nerve stimulation treatment can be preferably continued without adjusting the position of the stimulation lead.
  • the number of electrodes in the stimulation unit is not limited to three, and may be four or more.
  • a third embodiment of the present invention will be described with reference to FIG.
  • the difference between this embodiment and each of the above-described embodiments is the configuration of the electrocardiogram waveform acquisition unit and the processing of the control unit.
  • FIG. 12 is a schematic diagram showing the stimulation lead 60 in the present embodiment.
  • the electrocardiographic waveform acquisition unit 61 includes a third electrode 62 in addition to the pair of electrodes 37 and 38.
  • the third electrode 62 is attached between the pair of electrodes 37 and 38 in the longitudinal direction of the stimulation lead 60 and at a position closer to the proximal end than the stimulation unit 31.
  • the control unit 13 switches the electrodes for acquiring the electrocardiogram waveform according to the acquisition timing of the electrocardiogram waveform. That is, an electrocardiographic waveform is acquired between the pair of electrodes 37 and 38 when nerve stimulation is not performed.
  • an electrocardiographic waveform is acquired between the two electrodes 62 and 38 that are further from the heart Ht than the stimulation unit 31.
  • the electrocardiographic waveform acquired between the electrodes 37 and 38 is different from the electrocardiographic waveform acquired between the electrodes 62 and 38, and thus the reference used in the analyzing unit 12
  • a waveform is also prepared for each electrocardiogram waveform and is used properly in the determination.
  • the stimulation lead 60 and the nerve stimulation system including the stimulation lead 60 of the present embodiment the same effects as those of the nerve stimulation system 1 described above can be obtained.
  • the electrocardiogram waveform acquisition unit 61 includes the three electrodes 37, 38, and 62
  • the stimulation unit 31 is stimulated by appropriately selecting two electrodes that acquire an electrocardiogram waveform from the three electrodes. Even when a signal is applied, it is possible to reduce noise due to the stimulation signal and obtain a suitable electrocardiogram waveform. As a result, it is possible to monitor the movement of the stimulator in real time without interruption.
  • the number of electrodes of the electrocardiogram waveform acquisition unit is not limited to three, and may be four or more.
  • the electrocardiographic waveform changes when the selected electrodes are different, it is preferable to prepare a reference waveform for each necessary combination of electrodes from the viewpoint of highly accurate movement detection.
  • the number of electrodes of the electrocardiogram waveform acquisition unit is set to two and the two electrodes are arranged so as not to sandwich the stimulation unit in the longitudinal direction of the nerve stimulation electrode, noise can be constantly reduced. Is possible.
  • Each of the above embodiments can provide a movement detection method for a nerve stimulation electrode that preferably detects movement of the nerve stimulation electrode in a blood vessel, and the movement of the nerve stimulation electrode is preferably performed using the movement detection method for the nerve stimulation electrode. It is possible to provide a nerve stimulation electrode and a nerve stimulation system for detecting the above.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Human Computer Interaction (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

L'invention concerne un procédé de détection de déplacement d'une électrode de neurostimulation qui est implantée par voie intravasculaire, procédé selon lequel une forme d'onde d'électrocardiogramme est obtenue au niveau de l'électrode de neurostimulation et selon lequel on détermine s'il y a ou non déplacement de l'électrode de neurostimulation sur la base de la forme d'onde de l'électrocardiogramme.
PCT/JP2014/074049 2013-10-02 2014-09-11 Procédé de détection de déplacement d'électrode de neurostimulation, électrode de neurostimulation et système de neurostimulation WO2015049966A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013207527 2013-10-02
JP2013-207527 2013-10-02

Publications (1)

Publication Number Publication Date
WO2015049966A1 true WO2015049966A1 (fr) 2015-04-09

Family

ID=52778562

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/074049 WO2015049966A1 (fr) 2013-10-02 2014-09-11 Procédé de détection de déplacement d'électrode de neurostimulation, électrode de neurostimulation et système de neurostimulation

Country Status (1)

Country Link
WO (1) WO2015049966A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518143A (ja) * 1998-06-23 2002-06-25 カーディアック・ペースメイカーズ・インコーポレーテッド 心室リードから得られた検知期間を用いて埋込型右心房心内膜リードの移動を検出する方法およびシステム
JP2008534168A (ja) * 2005-04-01 2008-08-28 アドヴァンスド バイオニクス コーポレーション 神経刺激リードの位置および移動を検出するための装置および方法
JP2010540161A (ja) * 2007-10-02 2010-12-24 カーディアック ペースメイカーズ， インコーポレイテッド 個別の心筋接触領域を提供するリードアセンブリ

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518143A (ja) * 1998-06-23 2002-06-25 カーディアック・ペースメイカーズ・インコーポレーテッド 心室リードから得られた検知期間を用いて埋込型右心房心内膜リードの移動を検出する方法およびシステム
JP2008534168A (ja) * 2005-04-01 2008-08-28 アドヴァンスド バイオニクス コーポレーション 神経刺激リードの位置および移動を検出するための装置および方法
JP2010540161A (ja) * 2007-10-02 2010-12-24 カーディアック ペースメイカーズ， インコーポレイテッド 個別の心筋接触領域を提供するリードアセンブリ

Similar Documents

Publication Publication Date Title
CN108472490A (zh) 医疗设备系统中的传导通信
JP2013527007A5 (fr)
JP2011103981A (ja) 神経刺激装置
JP5872815B2 (ja) 神経刺激装置
US8600500B1 (en) Method and system to provide neural stimulation therapy to assist anti-tachycardia pacing therapy
CN105579098A (zh) 除颤器的自动除颤操作
EP3841999B1 (fr) Traitement combiné par stimulation cardiaque et électroporation irréversible (ire)
WO2015049966A1 (fr) Procédé de détection de déplacement d'électrode de neurostimulation, électrode de neurostimulation et système de neurostimulation
JP2014188157A (ja) 神経刺激システム及び神経刺激方法
US11565113B2 (en) Method for stimulating heart muscle activity during the refractory period
JP6942801B2 (ja) 心臓組織中で回転電気活動を終了または解消させる装置
US9037236B2 (en) Method and system to select a neurostimulation system configuration based on cardiac rhythm feedback
US8838253B2 (en) Nerve stimulating device
JP6000535B2 (ja) 刺激制御装置、刺激発生装置、ならびに神経刺激システム
JP5881326B2 (ja) 神経刺激装置、神経刺激システムおよび神経刺激装置の制御方法
JP5846816B2 (ja) 神経刺激装置
JP2012034843A (ja) 除細動システム
JP5695480B2 (ja) 神経刺激装置および神経刺激装置の作動方法
WO2016092611A1 (fr) Dispositif de stimulation nerveuse
JP5816408B2 (ja) 神経刺激装置
KR102045714B1 (ko) 제세동 카테터 시스템
WO2016038713A1 (fr) Dispositif de stimulation nerveuse, système de stimulation nerveuse et procédé de stimulation nerveuse
JP5653802B2 (ja) 神経刺激装置
JP5464924B2 (ja) 心臓治療装置
CN117241857A (zh) 用于抗心动过速起搏装置和方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14850587

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 14850587

Country of ref document: EP

Kind code of ref document: A1